Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye.
about
The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical ResearchThe role of lipids in corneal diseases and dystrophies: a systematic review.The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye.Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients
P2860
Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Presence or absence of ocular ...... apeutic management of dry eye.
@en
Presence or absence of ocular ...... apeutic management of dry eye.
@nl
type
label
Presence or absence of ocular ...... apeutic management of dry eye.
@en
Presence or absence of ocular ...... apeutic management of dry eye.
@nl
prefLabel
Presence or absence of ocular ...... apeutic management of dry eye.
@en
Presence or absence of ocular ...... apeutic management of dry eye.
@nl
P2860
P356
P1476
Presence or absence of ocular ...... apeutic management of dry eye.
@en
P2093
Robert Sambursky
P2860
P304
P356
10.2147/OPTH.S121256
P407
P577
2016-11-24T00:00:00Z